Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-06-06 Purchase | 2024-06-10 6:15 pm | Volato Group Inc. | SOAR | Heinen Mark Chief Financial Officer | 8,500 | $0.8 | $6,800 | 8,500 (Direct) | View |
2022-09-12 Purchase | 2022-09-14 4:37 pm | Better Therapeutics Inc. | BTTX | Heinen Mark See Remarks | 50,000 | $1.94 | $97,000 | 72,281 (Indirect Direct) | View |
2022-06-24 Purchase | 2022-06-28 4:24 pm | Better Therapeutics Inc. | BTTX | Heinen Mark See Remarks | 2,281 | $1.7539 | $4,000 | 22,281 (Indirect Direct) | View |
2022-06-10 Purchase | 2022-06-10 6:23 pm | Better Therapeutics Inc. | BTTX | Heinen Mark See Remarks | 5,000 | $1.56 | $7,800 | 20,000 (Direct) | View |
2022-03-31 Purchase | 2022-04-04 4:28 pm | Better Therapeutics Inc. | BTTX | Heinen Mark See Remarks | 5,000 | $1.98 | $9,900 | 47,800 (Direct) | View |
2021-12-13 Purchase | 2021-12-15 4:53 pm | Better Therapeutics Inc. | BTTX | Heinen Mark See Remarks | 3,333 | $4.9204 | $16,400 | 10,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-06-07 Option Award | 2024-06-11 6:48 pm | N/A N/A | Volato Group Inc. | SOAR | Heinen Mark Chief Financial Officer | 187,303 | $0 | 195,803 (Direct) | View |
2023-03-01 Option Award | 2023-04-21 6:14 pm | N/A 2033-02-28 | Better Therapeutics Inc. | BTTX | Heinen Mark Chief Financial Officer | 82,550 | $0 | 170,554 (Direct) | View |
2022-11-30 Option Award | 2022-12-02 4:15 pm | N/A N/A | Better Therapeutics Inc. | BTTX | Heinen Mark See Remarks | 15,723 | $1.241 | 88,004 (Direct) | View |
2022-04-01 Option Award | 2022-04-04 4:28 pm | N/A 2032-03-31 | Better Therapeutics Inc. | BTTX | Heinen Mark See Remarks | 32,800 | $0 | 47,800 (Direct) | View |
2021-10-28 Option Award | 2021-11-01 8:47 pm | N/A 2031-10-27 | Better Therapeutics Inc. | BTTX | Heinen Mark See Remarks | 58,587 | $0 | 85,253 (Direct) | View |
Ownership | 2021-11-01 8:35 pm | N/A N/A | Better Therapeutics Inc. | BTTX | Heinen Mark See Remarks | 0 | $0 | 6,667 (Direct) | View |